
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $184.4M | $395.4M | $477.9M | $501.5M | $522.2M | |
Revenue Growth (YoY) | -25.99% | 114.4% | 20.86% | 4.94% | 4.13% | |
Cost of Revenues | $84.7M | $177.7M | $218.3M | $232.3M | $241.4M | |
Gross Profit | $99.7M | $217.7M | $259.6M | $269.2M | $280.8M | |
Gross Profit Margin | 54.06% | 55.05% | 54.32% | 53.68% | 53.78% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $60.4M | $84.4M | $97.6M | $105.8M | $108.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $84.4M | $127.8M | $148.2M | $159M | $188.3M | |
Operating Income | $15.3M | $89.9M | $111.4M | $110.2M | $92.5M | |
Net Interest Expenses | $273K | $4.5M | $2.4M | $1.6M | $104K | |
EBT. Incl. Unusual Items | $15M | $85.4M | $109M | $108.5M | $92.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$8.7M | $16.9M | $21.5M | $26.1M | $19.6M | |
Net Income to Company | $23.7M | $68.5M | $87.5M | $82.4M | $72.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $23.7M | $68.5M | $87.5M | $82.4M | $72.8M | |
Basic EPS (Cont. Ops) | $1.30 | $3.68 | $4.60 | $4.28 | $3.91 | |
Diluted EPS (Cont. Ops) | $1.25 | $3.53 | $4.47 | $4.20 | $3.84 | |
Weighted Average Basic Share | $18.2M | $18.6M | $19M | $19.2M | $18.6M | |
Weighted Average Diluted Share | $18.9M | $19.4M | $19.6M | $19.6M | $19M | |
EBITDA | $32.6M | $128.3M | $154.9M | $157.4M | $143.9M | |
EBIT | $15.3M | $89.9M | $111.4M | $110.2M | $92.5M | |
Revenue (Reported) | $184.4M | $395.4M | $477.9M | $501.5M | $522.2M | |
Operating Income (Reported) | $15.3M | $89.9M | $111.4M | $110.2M | $92.5M | |
Operating Income (Adjusted) | $15.3M | $89.9M | $111.4M | $110.2M | $92.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $75M | $108.3M | $116.6M | $121.7M | $125.4M | |
Revenue Growth (YoY) | 46.95% | 44.5% | 7.69% | 4.3% | 3.07% | |
Cost of Revenues | $33.5M | $51M | $56.5M | $57.8M | $59.2M | |
Gross Profit | $41.5M | $57.4M | $60.1M | $63.8M | $66.2M | |
Gross Profit Margin | 55.33% | 52.96% | 51.54% | 52.48% | 52.79% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $19.9M | $24.2M | $25.1M | $27.1M | $27.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $30.2M | $36M | $37M | $40M | $40.9M | |
Operating Income | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Net Interest Expenses | $1.6M | $650K | $587K | -- | -- | |
EBT. Incl. Unusual Items | $9.7M | $20.7M | $22.6M | $23.8M | $25.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.5M | $2.6M | $4.9M | $5.5M | $5.8M | |
Net Income to Company | $8.2M | $18.1M | $17.7M | $18.3M | $19.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.2M | $18.1M | $17.7M | $18.3M | $19.9M | |
Basic EPS (Cont. Ops) | $0.44 | $0.96 | $0.92 | $0.95 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.42 | $0.92 | $0.90 | $0.93 | $1.05 | |
Weighted Average Basic Share | $18.5M | $18.9M | $19.2M | $19.3M | $18.5M | |
Weighted Average Diluted Share | $19.3M | $19.6M | $19.7M | $19.7M | $18.8M | |
EBITDA | $20.8M | $31.9M | $34.5M | $36.3M | $38.5M | |
EBIT | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Revenue (Reported) | $75M | $108.3M | $116.6M | $121.7M | $125.4M | |
Operating Income (Reported) | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Operating Income (Adjusted) | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $208.4M | $428.7M | $486.2M | $506.5M | $525.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $91.6M | $195.2M | $223.8M | $233.6M | $242.8M | |
Gross Profit | $116.7M | $233.6M | $262.3M | $272.9M | $283.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $63.1M | $88.7M | $98.5M | $107.8M | $108.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $92.3M | $133.6M | $149.1M | $162.1M | $189.2M | |
Operating Income | $24.4M | $99.9M | $113.3M | $110.8M | $94M | |
Net Interest Expenses | $1.9M | $3.5M | $2.4M | $1M | -- | |
EBT. Incl. Unusual Items | $22.6M | $96.4M | $110.9M | $109.8M | $94.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$7.3M | $18M | $23.9M | $26.7M | $19.9M | |
Net Income to Company | $29.8M | $78.5M | $87M | $83.1M | $74.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $29.8M | $78.5M | $87M | $83.1M | $74.4M | |
Basic EPS (Cont. Ops) | $1.62 | $4.20 | $4.56 | $4.31 | $5.18 | |
Diluted EPS (Cont. Ops) | $1.55 | $4.02 | $4.44 | $4.23 | $5.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $47.5M | $139.4M | $157.5M | $159.2M | $146.1M | |
EBIT | $24.4M | $99.9M | $113.3M | $110.8M | $94M | |
Revenue (Reported) | $208.4M | $428.7M | $486.2M | $506.5M | $525.9M | |
Operating Income (Reported) | $24.4M | $99.9M | $113.3M | $110.8M | $94M | |
Operating Income (Adjusted) | $24.4M | $99.9M | $113.3M | $110.8M | $94M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $75M | $108.3M | $116.6M | $121.7M | $125.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $33.5M | $51M | $56.5M | $57.8M | $59.2M | |
Gross Profit | $41.5M | $57.4M | $60.1M | $63.8M | $66.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $19.9M | $24.2M | $25.1M | $27.1M | $27.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $30.2M | $36M | $37M | $40M | $40.9M | |
Operating Income | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Net Interest Expenses | $1.6M | $650K | $587K | -- | -- | |
EBT. Incl. Unusual Items | $9.7M | $20.7M | $22.6M | $23.8M | $25.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.5M | $2.6M | $4.9M | $5.5M | $5.8M | |
Net Income to Company | $8.2M | $18.1M | $17.7M | $18.3M | $19.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.2M | $18.1M | $17.7M | $18.3M | $19.9M | |
Basic EPS (Cont. Ops) | $0.44 | $0.96 | $0.92 | $0.95 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.42 | $0.92 | $0.90 | $0.93 | $1.05 | |
Weighted Average Basic Share | $18.5M | $18.9M | $19.2M | $19.3M | $18.5M | |
Weighted Average Diluted Share | $19.3M | $19.6M | $19.7M | $19.7M | $18.8M | |
EBITDA | $20.8M | $31.9M | $34.5M | $36.3M | $38.5M | |
EBIT | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Revenue (Reported) | $75M | $108.3M | $116.6M | $121.7M | $125.4M | |
Operating Income (Reported) | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M | |
Operating Income (Adjusted) | $11.3M | $21.3M | $23.2M | $23.8M | $25.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $28.3M | $33.5M | $38.8M | $43.4M | $58.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.7M | $8.9M | $9.6M | $12M | $10.3M | |
Inventory | $7.8M | $7.2M | $7.6M | $7.6M | $9.3M | |
Prepaid Expenses | $8.4M | $7.6M | $8.5M | $11M | $10.6M | |
Other Current Assets | -- | -- | -- | -- | $10.6M | |
Total Current Assets | $73.2M | $84.1M | $89.4M | $75M | $90.4M | |
Property Plant And Equipment | $572.5M | $580.8M | $578.1M | $580.5M | $575.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $25.1M | $25.1M | $25.1M | $25.1M | $25.1M | |
Other Intangibles | $973K | $477K | $352K | $299K | $345K | |
Other Long-Term Assets | -- | -- | -- | -- | $418K | |
Total Assets | $671.9M | $690.5M | $692.9M | $680.9M | $691.6M | |
Accounts Payable | $11.7M | $18.6M | $14.4M | $23.1M | $41.2M | |
Accrued Expenses | $31.9M | $37.7M | $40.2M | $44.9M | $46M | |
Current Portion Of Long-Term Debt | $12.5M | $20M | $6.7M | -- | -- | |
Current Portion Of Capital Lease Obligations | $813K | $745K | $639K | $897K | $921K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $109.4M | $141.2M | $117.7M | $123.4M | $146.5M | |
Long-Term Debt | $167.2M | $68.2M | -- | $5.5M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $303.8M | $242.4M | $154M | $167.7M | $173.8M | |
Common Stock | $191K | $191K | $191K | $191K | $193K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $368.1M | $448M | $539M | $513.1M | $517.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $368.1M | $448M | $539M | $513.1M | $517.7M | |
Total Liabilities and Equity | $671.9M | $690.5M | $692.9M | $680.9M | $691.6M | |
Cash and Short Terms | $28.3M | $33.5M | $38.8M | $43.4M | $58.8M | |
Total Debt | $179.7M | $88.2M | $6.7M | $5.5M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $24.1M | $33.1M | $34.4M | $39.5M | $75.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $7.7M | $7.5M | $8M | $10.3M | $12M | |
Inventory | $7M | $7M | $6.9M | $7.4M | $8.3M | |
Prepaid Expenses | $7.3M | $7M | $7.7M | $9.3M | $7.9M | |
Other Current Assets | -- | -- | -- | -- | $7.9M | |
Total Current Assets | $69.5M | $79M | $57M | $66.5M | $103.3M | |
Property Plant And Equipment | $569.5M | $586.5M | $581.4M | $585.4M | $581.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $25.1M | $25.1M | $25.1M | $25.1M | $25.1M | |
Other Intangibles | $651K | $446K | $321K | $258K | $1.6M | |
Other Long-Term Assets | -- | -- | -- | -- | $354K | |
Total Assets | $665M | $691.1M | $663.8M | $677.3M | $712.1M | |
Accounts Payable | $12.4M | $19.4M | $15.2M | $21.4M | $38.8M | |
Accrued Expenses | $37.2M | $42.7M | $44.2M | $50.5M | $50.5M | |
Current Portion Of Long-Term Debt | $15M | $20M | -- | $5.5M | -- | |
Current Portion Of Capital Lease Obligations | $737K | $669K | $649K | $919K | $890K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $115.5M | $134.4M | $113.3M | $130.2M | $149.3M | |
Long-Term Debt | $142.5M | $58.5M | $51M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $285.1M | $225.9M | $200.4M | $168.4M | $176.5M | |
Common Stock | $191K | $191K | $191K | $192K | $194K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $379.9M | $465.2M | $463.4M | $508.9M | $535.6M | |
Total Liabilities and Equity | $665M | $691.1M | $663.8M | $677.3M | $712.1M | |
Cash and Short Terms | $24.1M | $33.1M | $34.4M | $39.5M | $75.1M | |
Total Debt | $157.5M | $78.5M | $51M | $5.5M | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.7M | $68.5M | $87.5M | $82.4M | $72.8M | |
Depreciation & Amoritzation | $17.3M | $38.4M | $43.4M | $47.3M | $51.4M | |
Stock-Based Compensation | $3.9M | $4.1M | $5.2M | $7.5M | $7.9M | |
Change in Accounts Receivable | -$23.1M | -$7.4M | $1.1M | $21.4M | $982K | |
Change in Inventories | -$1.1M | $664K | -$399K | -$56K | -$1.7M | |
Cash From Operations | $31.4M | $128.1M | $139.8M | $173M | $140.7M | |
Capital Expenditures | $88.7M | $46.9M | $39.5M | $49M | $47.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$46.4M | -$37.8M | -$48M | -$51.2M | -$43.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$112.8M | -$22.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $10.8M | -- | $3M | $71.5M | $45.5M | |
Long-Term Debt Repaid | -$24.6M | -$92.5M | -$86M | -$73M | -$51M | |
Repurchase of Common Stock | -- | -- | -$6.5M | -$5M | -$60M | |
Other Financing Activities | -$7.3M | -$730K | -$6.9M | -$464K | -$2M | |
Cash From Financing | -$17.3M | -$85.1M | -$86.5M | -$117.2M | -$81.5M | |
Beginning Cash (CF) | $60.5M | $28.3M | $33.5M | $38.8M | $43.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$32.2M | $5.2M | $5.3M | $4.6M | $15.4M | |
Ending Cash (CF) | $28.3M | $33.5M | $38.8M | $43.4M | $58.8M | |
Levered Free Cash Flow | -$57.2M | $81.2M | $100.3M | $124M | $93.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $18.1M | $19.4M | $22.4M | $22.7M | -- | |
Depreciation & Amoritzation | $9.4M | $10.5M | $11.6M | $12.4M | -- | |
Stock-Based Compensation | $1.2M | $1.1M | $1.3M | $1.8M | -- | |
Change in Accounts Receivable | -$2.6M | $67K | -$8.3M | -$5.8M | -- | |
Change in Inventories | $891K | -$723K | -$233K | -$733K | -- | |
Cash From Operations | $33.3M | $25.2M | $26.4M | $24.3M | -- | |
Capital Expenditures | $5.8M | $11.9M | $8.4M | $13.4M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$6M | -$13.2M | -$10.4M | -$12.8M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$5.7M | -$5.6M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $36M | -- | |
Long-Term Debt Repaid | -$25M | -$15M | -$10M | -$18.5M | -- | |
Repurchase of Common Stock | -- | -- | -- | -$30.8M | -- | |
Other Financing Activities | -$403K | -- | -- | -- | -- | |
Cash From Financing | -$23.2M | -$14.6M | -$15.3M | -$17.5M | -- | |
Beginning Cash (CF) | $24.1M | $33.1M | $34.4M | $39.5M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $4.2M | -$2.6M | $670K | -$6M | -- | |
Ending Cash (CF) | $28.3M | $30.6M | $35.1M | $33.5M | -- | |
Levered Free Cash Flow | $27.6M | $13.3M | $18M | $11M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $29.8M | $78.5M | $87M | $83.1M | $74.4M | |
Depreciation & Amoritzation | $23M | $39.4M | $44.3M | $48.4M | $52.1M | |
Stock-Based Compensation | $4.3M | $4M | $5.4M | $7.8M | $8.2M | |
Change in Accounts Receivable | -$26.8M | -$3.6M | $29.9M | -$1.6M | -$2.2M | |
Change in Inventories | -$79K | -$4K | $39K | -$433K | -$898K | |
Cash From Operations | $60.8M | $141.7M | $165.9M | $149.8M | $138.9M | |
Capital Expenditures | $84.3M | $55.3M | $39.4M | $51.9M | $49.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$38.6M | -$53.9M | -$41.1M | -$53.9M | -$41.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$95.6M | -$22.9M | -$22.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $10.8M | $3M | $61M | $20M | $36M | |
Long-Term Debt Repaid | -$47.1M | -$83M | -$90M | -$65.5M | -$41.5M | |
Repurchase of Common Stock | -- | -$6.5M | -- | -$24.6M | -$40.4M | |
Other Financing Activities | -- | -$3.2M | -$4.5M | -$403K | -- | |
Cash From Financing | -$37.4M | -$78.8M | -$123.5M | -$90.8M | -$61.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$15.2M | $9M | $1.3M | $5.1M | $35.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$23.5M | $86.4M | $126.4M | $97.9M | $89.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $26.3M | $37.6M | $40.1M | $41M | $19.9M | |
Depreciation & Amoritzation | $18.9M | $21.1M | $23M | $24.9M | $13.2M | |
Stock-Based Compensation | $2.5M | $2.3M | $2.8M | $3.6M | $2.1M | |
Change in Accounts Receivable | -$5.1M | $1.4M | $21.9M | $1.4M | $4M | |
Change in Inventories | $1.7M | -$536K | $392K | -$485K | $1M | |
Cash From Operations | $55.2M | $60.6M | $87.9M | $62.6M | $36.5M | |
Capital Expenditures | $12.2M | $26.7M | $23.2M | $31M | $19.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$11.9M | -$35.2M | -$25.6M | -$30.7M | -$16M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$101.3M | -$11.2M | -$5.5M | |
Special Dividend Paid | -- | -- | $5M | -- | -- | |
Long-Term Debt Issued | -- | $3M | $61M | $45.5M | -- | |
Long-Term Debt Repaid | -$47.5M | -$28M | -$27M | -$28M | -- | |
Repurchase of Common Stock | -- | -$6.5M | -- | -$50.4M | -- | |
Other Financing Activities | -$403K | -$2.5M | -$99K | -$38K | -- | |
Cash From Financing | -$43.3M | -$28.3M | -$66M | -$41.8M | -$4.1M | |
Beginning Cash (CF) | $52.5M | $66.7M | $73.2M | $82.8M | $58.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$14K | -$2.9M | -$3.7M | -$9.9M | $16.3M | |
Ending Cash (CF) | $52.4M | $63.7M | $69.5M | $73M | $75.1M | |
Levered Free Cash Flow | $43M | $33.9M | $64.7M | $31.6M | $16.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.